Moderna TX Inc. Deal History & Licensing Activity
Moderna TX Inc. is a life sciences. Over the past three years, Moderna TX Inc. has been involved in 8 licensing and acquisition transactions, with a primary focus on mRNA (9 deals). The company currently has 1 active clinical trial, primarily in Infectious Disease.
Deals (12mo)
1
Active Trials
1
Top Modality
mRNA
Focus Area
Infectious Disease
Moderna TX Inc. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Moderna TX Inc. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| mRNA-1018 | Moderna | mRNA | Phase 3 | collaboration | Dec 2025 |
Moderna TX Inc. Pipeline Focus
Therapeutic areas and modalities where Moderna TX Inc. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Moderna TX Inc. Clinical Pipeline
Moderna TX Inc. has 1 active clinical trial across 1 development phase.
1
Phase 1
See How Your Asset Matches Moderna TX Inc.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
Rare Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for rare disease
mRNA Benchmarks
Upfront, milestone, and royalty benchmarks for mrna deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About Moderna TX Inc. Licensing & Deal Activity
Moderna TX Inc. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 8 deals over the past three years, Moderna TX Inc. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Moderna TX Inc. include Infectious Disease (9 deals and trials), and Rare Disease (1 deal and trial). In terms of modality, Moderna TX Inc. has shown particular interest in mrna.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Moderna TX Inc. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Moderna TX Inc.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.